Press Releases

Nov 16 09 Aegerion Pharmaceuticals Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile
Jun 16 09 Aegerion Pharmaceuticals Announces Final Lomitapide (AEGR-733) Phase II Data
Jun 15 09

Aegerion Pharmaceuticals Announces Interim Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile

Dec 18 08 Aegerion Pharmaceuticals, Inc. to Present at the 27th Annual  J.P. Morgan Healthcare Conference
Presenting: Wednesday, January 14, 2009 at 3:00pm
Nov 24 08 Aegerion Pharmaceuticals, Inc. to Present at the Piper Jaffray 20th Annual Healthcare Conference
Nov 6 08 Aegerion Pharmaceuticals, Inc. Announces AEGR-733 Phase II Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile
Sep 4 08 Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
Oct 4 07 Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Aug 1 07 Aegerion Pharmaceuticals, Inc. Hires Vice President, General Counsel And Secretary
Jan 10 07

New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL by 51% in Patients With a Severe Form of Hypercholesterolemia

Nov 15 06 Aegerion Study Shows Combination Treatment With Aegr-733 And Zetia® Reduces LDL Levels By 35% After Four Weeks Of Therapy
Oct 6 06

Aegerion Pharmaceuticals Enters into Cross License Agreement

Jun 13 06

Aegerion Pharmaceuticals Completes $22.5 Million Series A Round; Financing Will Fund Additional Development Efforts in Dyslipidemia

   

Events

AHA Scientific Sessions 2009
November 14 – 18, 2009
Orange County Convention Center West
Orlando, Florida
Presenting: Abstract Poster Sessions
Monday, November 16, 2009/9:30am – 11:00am
Poster Hall A2-A3, Core 2, Poster Board 2011

XV International Symposium on Atherosclerosis
June 15 – 18, 2009
John B. Hynes Veterans Memorial Convention Center
Boston, MA
Lunch Symposium: Tuesday, June 16, 2009/Sheraton Boston Hotel
Republic Ballroom/12:30pm

JPMorgan 27th Annual Healthcare Conference
January 12 - 15, 2009
The Westin St. Francis
San Francisco, CA

Piper Jaffray 20th Annual Health Conference
December 2 - 3, 2008
The New York Palace
New York, NY
Presenting: Tuesday, December 2, 2008/12:10pm

Lazard Capital Markets 5th Annual Healthcare Conference
November 18 - 19, 2008
The St. Regis Hotel
New York, NY
Presenting: Tuesday, November 18, 2008/9:25am

AHA Scientific Sessions 2008
November 8 - 12, 2008
Ernest. N. Morial Convention Center
New Orleans, LA
Presenting: Abstract Poster Sessions/Tuesday, November 11, 2008
Hall A-B1/3:00pm - 4:30pm

AASLD/The Liver Meeting 2008
October 31 - November 4, 2008
Moscone West Convention Center
San Francisco, CA
Presenting: Poster Sessions/Sunday, November 2, 2008
West Hall (Moscone West Convention Center)/8:00am

The 7th Annual BIO Investor Forum
October 29 - 31, 2008
The Palace Hotel
San Francisco, CA
Presenting: Wednesday, October 29, 2008/2:45pm

Copyright ©2007 Aegerion Pharmaceuticals, Inc. All rights reserved.

Overview
Mission and Values
Senior Management Team
Board of Directors
Scientific Advisory Board
About MTPI
About Technology 2
Publications
Current
Press Release Archive
Article Archive
Current
Press Release Archive
Article Archive